Indian homegrown private equity (PE) major ChrysCapital is close to investing $100 million in Gujarat-based drug manufacturer Corona Remedies to help the latter fund its organic and inorganic expansion plans, DealStreetAsia has learnt.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
